Dr. Susannah Chatham Orzell, MD

Dr. Orzell practices at UCHealth Medical Group in Loveland, Colorado.

Dr. Orzell's NPI, 1962889485, was assigned on May 5, 2015. Dr. Orzell graduated from Boston University School Of Medicine in 2015. Dr. Orzell's Pennsylvania license number on file is MD477843.

Dr. Orzell's primary practice is UCHealth Medical Group, at 2695 Rocky Mountain Ave, Loveland, CO 80538 in Larimer County. The practice phone is (970) 624-4443.

Dr. Orzell's primary practice is UCHealth Medical Group in Loveland, Colorado. Dr. Orzell is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. Orzell to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orzell practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Orzell's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Orzell is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Orzell's licenses on file in 2 states: Pennsylvania and Colorado.

Dmand AI lists endoscopic sinus surgery, larynx and vocal cord disease, swimmer's ear and thyroid surgery among the conditions Dr. Orzell treats.

CMS data shows 193 Medicare services from Dr. Orzell across 8 procedure codes in 2024, for 112 Medicare patients. Medicare paid $18,306 for them. Every service was in an office.

CMS counts 112 Medicare patients who saw Dr. Orzell in 2024. The largest group is 65 to 74, with 52 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orzell's median patient age at 72, with 50% women.

In 2024, Dr. Orzell wrote 47 Medicare Part D claims for 28 patients. 85% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $63 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

Dr. Orzell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orzell as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Orzell, published from 2017 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Postoperative Complications, Head and Neck Neoplasms and Osteotomy. Dr. Orzell's most frequent co-authors are Joshua Robert Bedwell, MD, Michael John Daly, MD and Michael J. Daly, DO.

CMS Open Payments shows 6 general payments to Dr. Orzell from 5 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $141.

Dr. Orzell graduated from Boston University School Of Medicine in 2015.

Dr. Orzell is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.